Physician profile
Sandra Cottle
NPI 1427051549
$875.30
in general payments reported to CMS, 2019-2025
11 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.71 · 2022: $203 · 2023: $152 · 2024: $209 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $314.65 | 2022-2025 | Nexplanon, Jada System |
| Sage Therapeutics, LLC | $150.85 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $78.22 | 2021-2024 | |
| Abbvie INC. | $75.25 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.04 | 2023-2025 | |
| Astellas Pharma US INC | $49.69 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $45.71 | 2022 | |
| Hologic Sales and Service, LLC | $38.53 | 2022-2023 | Novasure, Acessa Provu System |
| Exact Sciences Corporation | $37.63 | 2023-2024 | Cologuard Collection Kit |
| Axonics, INC. | $17.02 | 2023 | Axonics |
| Therapeuticsmd, INC. | $14.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Cottle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.